Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

The World Health Organization (WHO) has warned that antimicrobial resistance could cause up to 39 million deaths worldwide over the next 25 years, raising concerns about the growing threat posed by drug-resistant infections.
The UN health agency said the increasing resistance of bacteria and other microorganisms to medicines is threatening the future of modern medicine and could make routine medical procedures, surgeries and childbirth increasingly dangerous.
Speaking at the 6th Annual Global Media Forum on Antimicrobial Resistance on Monday, Jean-Pierre Nyemazi, acting director of the WHO’s Antimicrobial Resistance Department, said global efforts to tackle the problem were progressing too slowly.
He explained that antimicrobial resistance (AMR), particularly antibiotic resistance, was already widespread and posed a serious threat to public health.
Unlike the COVID-19 pandemic, which attracted global attention, Nyemazi said drug-resistant infections had been claiming lives for years without receiving adequate attention.
According to WHO figures, antimicrobial resistance was directly responsible for more than one million deaths in 2021 and contributed to approximately 4.7 million additional deaths.
Progress in Tackling Antimicrobial Resistance
A review of efforts to combat antimicrobial resistance across 183 countries found that nearly nine out of every 10 countries had developed national action plans to address the problem.
This represents significant progress compared with 2017, when only about four in 10 countries had such plans.
However, Pravasha Prakash, an AMR technical officer at the WHO, said only 42 countries had action plans that were properly funded, implemented and monitored.
She stressed that countries needed to accelerate their efforts to achieve global targets set for 2030.
The WHO’s latest surveillance findings also revealed that one in every six laboratory-confirmed bacterial infections reported to the agency in 2023 was resistant to the antibiotics used to treat it.
Sylvia Bertagnolo, the WHO’s head of antimicrobial resistance surveillance, emphasised the importance of proper testing in identifying infections and determining effective treatment.
She warned that without adequate diagnostic testing, healthcare professionals could be forced to prescribe antibiotics without knowing the exact cause of an infection or which medication would work.
WHO Introduces New Diagnostic Tools
To strengthen global efforts against antimicrobial resistance, the WHO announced the introduction of two new tools to improve diagnostic services in healthcare facilities.
The first outlines the essential diagnostic tests that should be available at different levels of healthcare, ranging from primary healthcare centres to referral hospitals.
The second provides a collection of 73 laboratory procedures covering various stages of diagnosis, including sample collection, identification of disease-causing organisms and antibiotic susceptibility testing.
The agency said improving diagnostic capacity would help healthcare professionals identify infections more accurately and prescribe appropriate treatments.
It also highlighted infection prevention, vaccination, access to clean water and sanitation, and the responsible use of antimicrobial medicines as essential measures for tackling antimicrobial resistance.
The WHO has urged governments to strengthen their healthcare systems, invest in diagnostic facilities and accelerate the implementation of national action plans to prevent drug-resistant infections from becoming an even greater global health threat.
Join us on our WhatsApp Platform @KOIKIMEDIA NEWS YOUR PAGE
Koikimedia Bringing the World 🌎 Closer to Your Doorstep
[mc4wp_form id=2402]